While it didn’t warrant a mention in yesterday’s release, Kronos also has a partnership with Roche’s Genentech for several ...

Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine ...

Norwegian clinical-stage biotech Nykode Therapeutics revealed that it has received notification from Genentech, a US ...

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential ...

She has spent more than 30 years in biopharma circles, including five years as treasurer at Genentech. Kathleen Sereda Glaub, a longtime Bay Area biotech executive who took two companies to ...

Hello! Hope you had a restful and reflective Indigenous Peoples’ Day. Today, we talk about how the autoimmune disease space is hotter than ever, see more gene therapy contraction, and the CEO of ...

With climbing biotech M&A and IPO activity following the post-pandemic slump, experts offer insights on maximizing value and ...

Boyer was on the Genentech board of directors but deliberately ... asked Ptashne if he would be interested in starting a biotech company in which the university would have an equity position.

Biotech veteran Kathleen Sereda Glaub ... Glaub was treasurer at South San Francisco-based Genentech Inc. for five years until 1990 and CFO at Cell Genesys before spending 12 years at Plexxikon ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...